Iongen Therepeutics

About Iongen Therepeutics

Iongen Therapeutics develops novel pain therapeutics by targeting specific pain pathways. Their research focuses on creating non-addictive pain relief options for chronic and acute pain conditions.

```xml <problem> Current pain management strategies often rely on opioid-based medications, which carry a high risk of addiction and adverse side effects. There is a significant unmet need for non-addictive and effective pain relief options for both chronic and acute pain conditions. </problem> <solution> Iongen Therapeutics is a drug development company focused on creating novel, non-addictive pain therapeutics. The company's research targets specific sodium ion channels, Nav1.7 and Nav1.8, which are highly correlated with pain sensation in the body. By selectively modulating these channels, Iongen aims to develop innovative analgesics that provide effective pain relief without the risks associated with traditional opioid treatments. Their approach seeks to address the limitations of current pain management options by offering targeted and safer alternatives. </solution> <features> - Focus on Nav1.8 and Nav1.7 sodium ion channels for targeted pain relief - Development of non-addictive therapeutics to avoid opioid-related side effects - Research and development of novel drugs for both chronic and acute pain </features> <target_audience> The primary target audience includes individuals suffering from chronic and acute pain, as well as healthcare providers seeking safer and more effective pain management solutions. </target_audience> ```

What does Iongen Therepeutics do?

Iongen Therapeutics develops novel pain therapeutics by targeting specific pain pathways. Their research focuses on creating non-addictive pain relief options for chronic and acute pain conditions.

Where is Iongen Therepeutics located?

Iongen Therepeutics is based in Nanjing, China.

When was Iongen Therepeutics founded?

Iongen Therepeutics was founded in 2021.

Location
Nanjing, China
Founded
2021
0

Find Investable Startups and Competitors

Search thousands of startups using natural language

Iongen Therepeutics

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

Iongen Therapeutics develops novel pain therapeutics by targeting specific pain pathways. Their research focuses on creating non-addictive pain relief options for chronic and acute pain conditions.

iongentherapeutics.com
Founded 2021Nanjing, China

Funding

No funding information available.

Team

No team information available.

Company Description

Problem

Current pain management strategies often rely on opioid-based medications, which carry a high risk of addiction and adverse side effects. There is a significant unmet need for non-addictive and effective pain relief options for both chronic and acute pain conditions.

Solution

Iongen Therapeutics is a drug development company focused on creating novel, non-addictive pain therapeutics. The company's research targets specific sodium ion channels, Nav1.7 and Nav1.8, which are highly correlated with pain sensation in the body. By selectively modulating these channels, Iongen aims to develop innovative analgesics that provide effective pain relief without the risks associated with traditional opioid treatments. Their approach seeks to address the limitations of current pain management options by offering targeted and safer alternatives.

Features

Focus on Nav1.8 and Nav1.7 sodium ion channels for targeted pain relief

Development of non-addictive therapeutics to avoid opioid-related side effects

Research and development of novel drugs for both chronic and acute pain

Target Audience

The primary target audience includes individuals suffering from chronic and acute pain, as well as healthcare providers seeking safer and more effective pain management solutions.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.